Jamjureeruk V, Kirawittaya T, Ningsnondh V
Pediatric Cardiology Unit, Queen Sirikit National Institute of Child Health (Children's Hospital), Bangkok, Thailand.
Cardiol Young. 1999 Jan;9(1):58-62. doi: 10.1017/s1047951100007393.
One of the important complications of transcatheter occlusion of the patent duct by insertion of either the Rashkind double umbrella or coil devices is intravascular haemolysis, particularly the severe form which occurs in 0.5-0.6% of cases. The incidence of subclinical or mild intravascular haemolysis including morphologic changes in the red cells, however, is not known, especially in the group of patients with residual shunt. We studied laboratory and haematologic changes in 37 patients subsequent to transcatheter occlusion. Their ages ranged from 2 years 2 months to 11 years 8 months (6.2 + 2.7 years), and the duration of occlusion had ranged from 1 month to 2 years 11 months (1.24 + 0.89 years). In 30 cases we had used the Rashkind double umbrella device, and nine of these patients (30%) had a residual shunt. The other seven ducts were closed with detachable coils, and five of these cases (71%) had residual shunting. There was evidence of mild or subclinical intravascular haemolysis in almost half the cases, although no patient developed acute intravascular haemolysis. Fragmented red cells, blur cells and spherocytes from blood smears were found in up to one-third of the overall series, with no differences found according to persistence of shunting. Haemosiderin was found in the urine of the group with residual shunting and in 13-23% of those with complete occlusion. Serum hypohaptoglobin was found in 9-13% of the patients with a residual shunt, and in 9-23% of those with complete occlusion. Four of the patients had haptoglobin levels < 50 mg/dl. There were no patients with reticulocytes counts > 2% in the blood smears. We conclude that subclinical or mild intravascular haemolysis, along with morphologic changes in the red blood cells, are significant findings subsequent to occlusion of the patent arterial duct with either the Rashkind double umbrella or detachable coils.
通过插入Rashkind双伞装置或弹簧圈装置经导管封堵动脉导管未闭的重要并发症之一是血管内溶血,尤其是严重形式的血管内溶血,其发生率在0.5% - 0.6%的病例中出现。然而,亚临床或轻度血管内溶血的发生率,包括红细胞形态学变化,尚不清楚,特别是在有残余分流的患者群体中。我们研究了37例经导管封堵术后患者的实验室和血液学变化。他们的年龄从2岁2个月到11岁8个月(平均6.2±2.7岁),封堵持续时间从1个月到2年11个月(平均1.24±0.89年)。在30例中我们使用了Rashkind双伞装置,其中9例患者(30%)有残余分流。另外7例动脉导管用可拆弹簧圈封堵,其中5例(71%)有残余分流。几乎一半的病例有轻度或亚临床血管内溶血的证据,尽管没有患者发生急性血管内溶血。在整个系列中,高达三分之一的病例血涂片发现破碎红细胞、模糊细胞和球形红细胞,根据分流持续情况未发现差异。残余分流组以及13% - 23%完全封堵组患者的尿液中发现含铁血黄素。残余分流患者中有9% - 13%、完全封堵患者中有9% - 23%发现血清触珠蛋白降低。4例患者触珠蛋白水平<50mg/dl。血涂片中没有网织红细胞计数>2%的患者。我们得出结论,亚临床或轻度血管内溶血以及红细胞形态学变化是使用Rashkind双伞装置或可拆弹簧圈封堵动脉导管未闭后的重要发现。